Genome International Biomedical Co. Ltd filed its Annual on Mar 31, 2014 for the period ending Dec 31, 2013. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26 TWD | +2.97% | -4.06% | -24.42% |
1st Jan change | Capi. | |
---|---|---|
-24.42% | 34.54M | |
+27.42% | 76.83B | |
-0.60% | 24.51B | |
+7.82% | 8.69B | |
+10.46% | 8.33B | |
-25.33% | 7.53B | |
+15.02% | 5.21B | |
+1.24% | 4.09B | |
-8.45% | 3.86B | |
-3.20% | 3.54B |
- Stock Market
- Equities
- 6130 Stock
- News Shangya Technology Co., Ltd.
- Genome International Biomedical Co. Ltd Auditor Raises 'Going Concern' Doubt